|
Product
|
TPO, Human
|
|
Cat#
|
101-28-04A
|
|
Sequence
|
SPAPPACDLR VLSKLLRDSH VLHSRLSQCP EVHPLPTPVL
LPAVDFSLGE WKTQMEETKA QDILGAVTLL LEGVMAARGQ
LGPTCLSSLL GQLSGQVRLL LGALQSLLGT QLPPQGRTTA
HKDPNAIFLS FQHLLRGKVR FLMLVGGSTL CVRRAPPTTA
VPSRTSLVLT LNELPNRTSG LLETNFTASA RTTGSGLLKW
QQGFRAKIPG LLNQTSRSLD QIPGYLNRIH ELLNGTRGLF
PGPSRRTLGA PDISSGTSDT GSLPPNLQPG YSPSPTHPPT
GQYTLFPLPP TLPTPVVQLH PLLPDPSAPT PTPTSPLLNT
SYTHSQNLSQ EG
|
|
Unit/Weight
|
10 μg
|
|
Unit Price
|
$152.00
|
|
Description
|
Thrombopoietin (Tpo), the ligand for the receptor encoded by the c-Mpl proto-oncogene, is a key regulator of megakaryocytopoiesis and thrombopoiesis in vitro and in vivo. The cDNAs for Tpo have recently been cloned from canine, mouse and human sources. The proteins from these three species are highly conserved, exhibiting from 69-75% sequence identity at the amino acid level. Human Tpo cDNA encodes a 353 amino acid residue protein with a 21 amino acid residue signal peptide that is cleaved to yield the 332 amino acid residue mature protein. Two distinct domains, separated by a pair of arginine residues that may be a proteolytic cleavage site, have been identified in Tpo: the amino terminal region exhibiting sequence homology to erythropoietin and the carboxy terminal region containing multiple potential N-linked glycosylation sites. Recombinant Tpo has now been shown to stimulate the maturation, as well as the proliferation, of megakaryocytes and may have important therapeutic applications for the treatment of various clinical conditions associated with thrombocytopenia.
|
|
Molecular Weight
|
Approximately 80 kDa, consisting of a 332 amino acid residue with a predicted molecular mass of approximately 35 kDa. As a result of glycosylation, the recombinant protein migrates with an apparent molecular mass of 80?0 kDa in SDS-PAGE.
|
|
Purity
|
> 98 % by SDS-PAGE and HPLC analyses.
|
|
Storage
|
This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
|
|